ESBATech's Other Investors

ESBATech raised a round of funding on , .

ESBATech develops therapeutic single-chain fragment antibodies on the basis of its fully human antibody fragments for the treatment of various inflammatory diseases. The established know-how and exper…

Articles about ESBATech's Other Investors: